The Italian Network for Tumor Biotherapy (NIBIT): past, present and future goals

Authors

  • Michele Maio Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy NIBIT – Network Italiano per la Bioterapia dei Tumori
  • Ester Fonsatti Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy NIBIT – Network Italiano per la Bioterapia dei Tumori

DOI:

https://doi.org/10.7175/rhc.v5i1.896

Keywords:

Italian Network for Tumor Biotherapy, NIBIT

References

Hodi FS, O’Day SJ, McDermott DF, et al.. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711-23; http://dx.doi.org/10.1056/NEJMoa1003466

Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507-16; http://dx.doi.org/10.1056/NEJMoa1103782

Calabrò L, Morra A, Fonsatti E, et al. Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial. Lancet Oncol 2013; 14: 1104-11; http://dx.doi.org/10.1016/S1470-2045(13)70381-4

Di Giacomo AM, Ascierto PA, Pilla L, et al. Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial. Lancet Oncol 2012; 13: 879-86; http://dx.doi.org/10.1016/S1470-2045(12)70324-8

Downloads

Published

2014-01-30

Issue

Vol. 5 No. 1 (2014)

Section

Editorial

License

Authors who publish with this journal agree to the following terms:
  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
  4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)